
Associated Press - Thursday December 21, 2000
The releases caused the stock of New Technologies' parent company, Uniprime Capital Acceptance Inc., to rise from 62 cents a share to $7.93 per share, only to collapse once the fraud was revealed, prosecutors said. Prosecutors said Flores boasted in press releases that he had conducted tests in 1990 on patients in Madrid that completely reversed the patients' HIV infections "with no reintroduction of the virus after nearly 18 months."
Flores actually was in prison at the time in Colorado after he was convicted in a murder conspiracy, the prosecutors said.
Flores, incarcerated since his August 1999 arrest, was scheduled to be sentenced April 6 by U.S. District Judge Kimba M. Wood. He faces up to 10 years in prison and a $1 million fine.
001221
AP001218
Copyright © 2000 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.
Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .